集成批量和单细胞转录基因数据,以识别阿尔茨海默氏症疾病中的铁亡相关炎症基因
Huiqin Zhou1,2,3, Yunjia Peng2,3, Xinhua Huo2,3
1College of Life Sciences, Hunan Normal University, Changsha, People's Republic of China.
Journal of inflammation research
|February 17, 2025
概括
这项研究确定SLC11A1是阿尔茨海默病 (AD) 的关键基因,将铁亡和神经炎症联系起来. 微质和单细胞中SLC11A1升高表明AD发展和潜在治疗点的新途径.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 铁,一种依赖于铁的细胞死亡,与各种疾病有关,但其在阿尔茨海默氏症 (AD) 神经炎症和脑外围轴中的作用尚不清楚.
- 了解铁,免疫反应和AD病原体之间的分子联系对于开发有效的治疗方法至关重要.
研究的目的:
- 在阿尔茨海默病中研究连接铁亡,免疫炎症和脑外周血液轴的细胞和分子机制.
- 通过使用集成的多omics数据,识别参与AD病变发生的新型候选基因和途径.
主要方法:
- 从AD大脑和外围血液中集成的批量和单细胞RNA测序 (RNA-seq).
- 不同基因表达分析,加权基因共表达网络分析 (WGCNA) 和细胞类型特定分析.
- 在ferroptosis模型中使用RT-qPCR和免疫光学验证候选基因.
主要成果:
- 发现SLC11A1,一种炎症基因,在AD大脑微质细胞和外周血液单细胞中显著上调.
- 与铁死相关的特定的M1型微质子群表达了外围单细胞标记物,表明神经炎症的潜在起源和作用.
- 实验验证证证实SLC11A1在ferroptosis诱导的炎症性微质细胞中的上调.
结论:
- SLC11A1在阿尔茨海默氏症中发挥着关键作用,特别是在铁死介导的神经炎症中.
- 这项研究为涉及大脑外围轴的AD病变发生提供了新的分子机理洞察力.
- 确定SLC11A1作为阿尔茨海默病的潜在治疗点.
相关概念视频
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...